Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
6,235,531
-
Total 13F shares
-
3,723,565
-
Share change
-
-971,621
-
Total reported value
-
$34,207,000
-
Price per share
-
$9.20
-
Number of holders
-
19
-
Value change
-
-$9,901,055
-
Number of buys
-
10
-
Number of sells
-
14
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) as of Q2 2018
As of 30 Jun 2018 BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) had 19 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 3,723,565 shares of stock of the company.
Largest 10 holders included FMR LLC, Artemis Investment Management LLP, VANGUARD GROUP INC, CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM, Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, Prudence Asset Management Ltd, Marshall Wace North America L.P., BlackRock Inc., and Dean Capital Investments Management, LLC.
This table shows 19 institutional shareholders of the security as of 30 Jun 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.